These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials. Wu L; Zhang Z; Yao H; Liu K; Wen Y; Xiong L Drug Des Devel Ther; 2014; 8():2061-7. PubMed ID: 25378911 [TBL] [Abstract][Full Text] [Related]
5. A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors. Mahadevan D; Cooke L; Riley C; Swart R; Simons B; Della Croce K; Wisner L; Iorio M; Shakalya K; Garewal H; Nagle R; Bearss D Oncogene; 2007 Jun; 26(27):3909-19. PubMed ID: 17325667 [TBL] [Abstract][Full Text] [Related]
6. Cas-L was overexpressed in imatinib-resistant gastrointestinal stromal tumor cells. Thao le B; Vu HA; Yasuda K; Taniguchi S; Yagasaki F; Taguchi T; Watanabe T; Sato Y Cancer Biol Ther; 2009 Apr; 8(8):683-8. PubMed ID: 19417561 [TBL] [Abstract][Full Text] [Related]
7. Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients. Garner AP; Gozgit JM; Anjum R; Vodala S; Schrock A; Zhou T; Serrano C; Eilers G; Zhu M; Ketzer J; Wardwell S; Ning Y; Song Y; Kohlmann A; Wang F; Clackson T; Heinrich MC; Fletcher JA; Bauer S; Rivera VM Clin Cancer Res; 2014 Nov; 20(22):5745-5755. PubMed ID: 25239608 [TBL] [Abstract][Full Text] [Related]
8. Selecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations. Hsueh YS; Lin CL; Chiang NJ; Yen CC; Li CF; Shan YS; Ko CH; Shih NY; Wang LM; Chen TS; Chen LT PLoS One; 2013; 8(6):e65762. PubMed ID: 23840364 [TBL] [Abstract][Full Text] [Related]
9. Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants. Zhao J; Quan H; Xu Y; Kong X; Jin L; Lou L Cancer Sci; 2014 Jan; 105(1):117-25. PubMed ID: 24205792 [TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors. Antonescu C Curr Top Microbiol Immunol; 2012; 355():41-57. PubMed ID: 22015552 [TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal stromal tumor: a bridge between bench and bedside. Nishida T; Takahashi T; Miyazaki Y Gastric Cancer; 2009; 12(4):175-88. PubMed ID: 20047122 [TBL] [Abstract][Full Text] [Related]
12. C-kit, GIST, and imatinib. Siehl J; Thiel E Recent Results Cancer Res; 2007; 176():145-51. PubMed ID: 17607922 [TBL] [Abstract][Full Text] [Related]